AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 260: E477-E485, 1991;
0193-1849/91 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Braun, J. E.
Right arrow Articles by Severson, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Braun, J. E.
Right arrow Articles by Severson, D. L.

AJP - Endocrinology and Metabolism, Vol 260, Issue 3 E477-E485, Copyright © 1991 by American Physiological Society

ARTICLES

Diabetes reduces heparin- and phospholipase C-releasable lipoprotein lipase from cardiomyocytes

J. E. Braun and D. L. Severson
Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Calgary, Alberta, Canada.

Incubation of isolated cardiac myocytes from rat hearts with heparin or phosphatidylinositol-specific phospholipase C (PLC) resulted in the release of lipoprotein lipase (LPL) into the medium. The release of LPL by the combination of heparin and PLC was not additive, and preincubation of cardiac myocytes with heparin eliminated the release of LPL in a subsequent incubation with PLC. This evidence suggests that LPL may be bound ionically to heparan sulfate proteoglycans that are covalently linked to the cell surface of cardiac myocytes by a phosphatidylinositol-glycan membrane anchor; a second pool of LPL may also be bound to proteoglycans attached directly to the myocardial cell surface. The induction of diabetes by the administration of streptozotocin (100 mg/kg for 3-4 days) to rats resulted in a decrease in the initial cellular activity of LPL and a marked reduction in the heparin-induced secretion of LPL into the medium of cardiac myocytes. The intravenous administration of insulin (5 U for 1 h) in diabetic rats reversed the effects of diabetes on cellular and heparin-releasable LPL activities. Diabetes also reduced the PLC-induced release of LPL. The reduction in the release of LPL from diabetic cardiac myocytes could result in a decrease in functional LPL activity at the capillary endothelium of whole hearts.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
R. Carroll and D. L. Severson
Peroxisome proliferator-activated receptor-{alpha} ligands inhibit cardiac lipoprotein lipase activity
Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H888 - H894.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
X. Wang, D. G. Hole, T. H. M. Da Costa, and R. D. Evans
Alterations in myocardial lipid metabolism during lactation in the rat
Am J Physiol Endocrinol Metab, August 1, 1998; 275(2): E265 - E271.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
L. G. Anderson, R. Carroll, H. S. Ewart, A. Acharya, and D. L. Severson
Fatty acids reduce heparin-releasable LPL activity in cultured cardiomyocytes from rat heart
Am J Physiol Endocrinol Metab, October 1, 1997; 273(4): E759 - E767.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online